Protara Therapeutics (TARA) Stock Price Target 2026

The average analyst price target for Protara Therapeutics is $22.64, 897.4% above the current price. Of 8 analysts, 8 rate it Buy. Targets range from $12 to $28. The latest change came on May 20, 2026, when Oppenheimer raised its price target on Protara Therapeutics from $25 to $28 and kept an Outperform rating.